Lynx1 Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,194	Closed	-$30.4K	–	23
2024 Q3	$30.4K	Hold	16,194	–	–	0.01%	18
2024 Q2	$31.9K	Buy	+16,194	New	+$31.9K	0.01%	17